# Oxford Pharmaceuticals, LLC – FDA Inspection, Sep 2, 2026

Source: https://www.keypedia.com/records/fda_inspections/oxford-pharmaceuticals-llc/4e4530db-12c1-4327-b044-4ed5c783ab5a
Source feed: FDA_Inspections

> FDA inspection 1334078 of Oxford Pharmaceuticals, LLC, September 02, 2026. 2 citations under 21 CFR part 211. Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1334078
- Company Name: Oxford Pharmaceuticals, LLC
- Inspection Date: 2026-09-02
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: New Orleans District Office
- Citation Count: 2

## Related Documents

- [FDA Inspection 1221787 - 2023-11-03](https://www.keypedia.com/records/fda_inspections/oxford-pharmaceuticals-llc/0e32951c-75a0-4d53-b01e-ec21522685b5)
- FDA Inspection 1174389 - 2022-06-08
- [FDA Inspection 1092451 - 2019-05-22](https://www.keypedia.com/records/fda_inspections/oxford-pharmaceuticals-llc/820c91ad-1442-4bd2-96b0-84faa633141e)

## Related Officers

- [Company Rep](https://www.keypedia.com/people/inga-m-warr/f27805b8-c2ba-4af5-bf5e-ff2e2f511ec1)

Company: https://www.keypedia.com/companies/oxford-pharmaceuticals-llc/5294310a-05a2-4599-bf9e-720929f040ee

Office: https://www.keypedia.com/offices/new-orleans-district-office/95352142-b992-4e06-849d-d7483c0959ea